Wednesday, May 18, 2022 1:11:24 PM
This complaint, I think, charges the two aforementioned MM’ers with violation of Section 4, of the Sherman Act. The number of Plaintiffs that can be added to this complaint may, or may not, be beneficial to a positive outcome for Xall’s investors. If interested, that’s something for each of you to consider. Following is a list of complaints, that either CDEL or ETRF have singularly or collectively engaged in:
* CDEL and ETRF, have maintained a wide inside spread on Xall
for nearly 3 years, increasing SH’ers and other investors transaction
cost.
* price competition amongst other Market Makers have been restricted
as CDEL and ETRF have forced compliance with their spreads.
* Shareholders and investors trading Xalles have been deprived of a free
and open competition, via CDEL’s and ETRF’s manipulation.
* the inside spread on Xalles, manipulated by CDEL and ETRF, have
been wider than it should in a competitive market, thus creating higher c
cost for shareholders and investors.
* Xalles Holdings (Xalls) is a profitable company listed on OTC-Pink,
that has performed better than other stocks with less restrictive
inside spreads.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM